Camp4 Therapeutics (CAMP) Non Operating Income (2023 - 2026)
Camp4 Therapeutics recorded quarterly Non Operating Income of $18000.0 in Q1 2026, up 100.06% quarter-over-quarter from -$27.8 million in Q4 2025, and down 97.3% year-over-year from $667000.0 in Q1 2025.
Camp4 Therapeutics' Non Operating Income history runs 4 years deep, the most recent figure standing at $18000.0 for Q1 2026.
- In Q1 2026, Non Operating Income fell 97.3% year-over-year to $18000.0; the TTM figure through Mar 2026 stood at -$28.8 million (down 1521.04% YoY), while the FY2025 annual figure was -$27.8 million, down 2247.11% from the prior year.
- Non Operating Income came in at $18000.0 for Q1 2026 at Camp4 Therapeutics, up from -$27.8 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $1.5 million in Q4 2024 to a low of -$27.8 million in Q4 2025.
- A 4-year average of -$2.3 million and a median of $32000.0 in 2024 frame the typical range for Non Operating Income.
- On a YoY basis, Non Operating Income climbed as much as 2282.14% in 2025 and fell as far as 4625.0% in 2025.
- Camp4 Therapeutics' Non Operating Income stood at $486000.0 in 2023, then surged by 203.5% to $1.5 million in 2024, then tumbled by 1987.73% to -$27.8 million in 2025, then soared by 100.06% to $18000.0 in 2026.
- According to Business Quant data, Non Operating Income over the past three periods registered $18000.0, -$27.8 million, and -$1.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 444,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 201.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -46.98 Mn |
| 10 | Camp4 Therapeutics | 245.89 Mn | 245.89 Mn | - | 18,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18,000.00 |
| Dec 31, 2025 | -27.84 Mn |
| Sep 30, 2025 | -1.45 Mn |
| Jun 30, 2025 | 441,000.00 |
| Mar 31, 2025 | 667,000.00 |
| Dec 31, 2024 | 1.48 Mn |
| Sep 30, 2024 | 32,000.00 |
| Jun 30, 2024 | -145,000.00 |
| Mar 31, 2024 | 28,000.00 |
| Dec 31, 2023 | 486,000.00 |
| Sep 30, 2023 | 642,000.00 |